Literature DB >> 31098602

Unexpected therapeutic effects of cisplatin.

Martina Raudenska1, Jan Balvan2, Michaela Fojtu1, Jaromir Gumulec2, Michal Masarik3.   

Abstract

Cisplatin is a widely used chemotherapeutic agent that is clinically approved to fight both carcinomas and sarcomas. It has relatively high efficiency in treating ovarian cancers and metastatic testicular cancers. It is generally accepted that the major mechanism of cisplatin anti-cancer action is DNA damage. However, cisplatin is also effective in metastatic cancers and should, therefore, affect slow-cycling cancer stem cells in some way. In this review, we focused on the alternative effects of cisplatin that can support a good therapeutic response. First, attention was paid to the effects of cisplatin at the cellular level such as changes in intracellular pH and cellular mechanical properties. Alternative cellular targets of cisplatin, and the effects of cisplatin on cancer cell metabolism and ER stress were also discussed. Furthermore, the impacts of cisplatin on the tumor microenvironment and in the whole organism context were reviewed. In this review, we try to reveal possible causes of the unexpected effectiveness of this anti-cancer drug.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31098602     DOI: 10.1039/c9mt00049f

Source DB:  PubMed          Journal:  Metallomics        ISSN: 1756-5901            Impact factor:   4.526


  14 in total

1.  Property evaluation of two anticancer candidate platinum complexes with N-isobutyl glycine ligand against human colon cancer.

Authors:  Zahra Hosseini Hashemi; Masoud Mirzaei; Mahboube Eslami Moghadam
Journal:  Biometals       Date:  2022-07-13       Impact factor: 3.378

2.  Effects of dihydroartemisinin combined with cisplatin on proliferation, apoptosis and migration of HepG2 cells.

Authors:  Qi Rao; Ruochan Li; He Yu; Lei Xiang; Bin He; Fenghua Wu; Gang Zhao
Journal:  Oncol Lett       Date:  2022-06-22       Impact factor: 3.111

Review 3.  Target-specific mononuclear and binuclear rhenium(i) tricarbonyl complexes as upcoming anticancer drugs.

Authors:  Ajay Sharma S; Vaibhavi N; Binoy Kar; Utpal Das; Priyankar Paira
Journal:  RSC Adv       Date:  2022-07-14       Impact factor: 4.036

4.  Clinically Relevant Chemotherapeutics Have the Ability to Induce Immunogenic Cell Death in Non-Small Cell Lung Cancer.

Authors:  Tal Flieswasser; Jinthe Van Loenhout; Laurie Freire Boullosa; Astrid Van den Eynde; Jorrit De Waele; Jonas Van Audenaerde; Filip Lardon; Evelien Smits; Patrick Pauwels; Julie Jacobs
Journal:  Cells       Date:  2020-06-16       Impact factor: 6.600

Review 5.  Hydrogen Ion Dynamics of Cancer and a New Molecular, Biochemical and Metabolic Approach to the Etiopathogenesis and Treatment of Brain Malignancies.

Authors:  Salvador Harguindey; Julian Polo Orozco; Khalid O Alfarouk; Jesús Devesa
Journal:  Int J Mol Sci       Date:  2019-09-01       Impact factor: 5.923

6.  Building up PtII -Thiosemicarbazone-Lysine-sC18 Conjugates.

Authors:  Alexander Haseloer; Tamara Lützenburg; Joss Pepe Strache; Jörg Neudörfl; Ines Neundorf; Axel Klein
Journal:  Chembiochem       Date:  2020-11-06       Impact factor: 3.164

7.  Synergic fabrication of pembrolizumab loaded doxorubicin incorporating microbubbles delivery for ultrasound contrast agents mediated anti-proliferation and apoptosis.

Authors:  Huilin Liu; Xing Li; Zihe Chen; Lianjie Bai; Ying Wang; Weiyang Lv
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.819

Review 8.  A New and Integral Approach to the Etiopathogenesis and Treatment of Breast Cancer Based upon Its Hydrogen Ion Dynamics.

Authors:  Salvador Harguindey; Khalid Alfarouk; Julián Polo Orozco; Kevin Hardonniere; Daniel Stanciu; Stefano Fais; Jesús Devesa
Journal:  Int J Mol Sci       Date:  2020-02-07       Impact factor: 5.923

9.  Mono-, Di- and Tetra-iron Complexes with Selenium or Sulphur Functionalized Vinyliminium Ligands: Synthesis, Structural Characterization and Antiproliferative Activity.

Authors:  Gabriele Agonigi; Lucinda K Batchelor; Eleonora Ferretti; Silvia Schoch; Marco Bortoluzzi; Simona Braccini; Federica Chiellini; Lorenzo Biancalana; Stefano Zacchini; Guido Pampaloni; Biprajit Sarkar; Paul J Dyson; Fabio Marchetti
Journal:  Molecules       Date:  2020-04-03       Impact factor: 4.411

Review 10.  Towards an Integral Therapeutic Protocol for Breast Cancer Based upon the New H+-Centered Anticancer Paradigm of the Late Post-Warburg Era.

Authors:  Salvador Harguindey; Khalid Alfarouk; Julián Polo Orozco; Stefano Fais; Jesús Devesa
Journal:  Int J Mol Sci       Date:  2020-10-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.